| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |